Market Tracker

02/17 5:16pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.38
Delayed Data
As of Feb 17
 -0.30 / -6.41%
Today’s Change
1.65
Today|||52-Week Range
18.40
+151.72%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close4.68
Today’s open4.50
Day’s range4.21 - 4.68
Volume580,865
Average volume (3 months)565,038
Market cap$63.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-71.87%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.02+1.16%
STDYSteadymed Ltd0.000.00%
EPIXESSA Pharma Inc-0.12-5.11%
NBYNovaBay Pharmaceutic...0.000.00%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$1.58
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts